TABLE 2.
Method | Multi-omics | Literature | Application | Throughput |
T-ATAC-seq | ATAC + RNA | Satpathy et al. (2018) | Immune profiling | Low |
scCAT-seq | ATAC + RNA | Liu et al. (2019) | Embryonic development | Low |
sci-CAR | ATAC + RNA | Cao et al. (2018) | NA | High |
Paired-seq | ATAC + RNA | Zhu et al. (2019) | Brain development | High |
scNMT-seq | Methylation + ATAC + RNA | Clark et al. (2018); Argelaguet et al. (2019) | Embryonic development | Low |
scTrio-seq | Methylation + RNA + DNA copy number | Hou et al. (2016); Bian et al. (2018) | Tumor heterogeneity | Low |
scCOOL-seq | Methylation + ATAC + DNA copy number | Guo et al. (2017); Li L. et al. (2018) | Embryonic development | Low |
scNOMe-seq | Methylation + ATAC | Pott (2017) | Technology development | Low |
Methyl-Hi C | Methylation + Hi C | Li G. et al. (2019) | NA | Low |
CITE-seq | RNA + epitope | Stoeckius et al. (2017) | Immune profiling | High |
Pi-ATAC | RNA + epitope | Chen et al. (2018) | Immune profiling | Low |
REAP-seq | RNA + epitope | Peterson et al. (2017) | Immune profiling | High |
ECCITE-seq | RNA + epitope + CRISPR | Mimitou et al. (2019) | Immune profiling | High |
Slide-seq | Spatial + RNA | Rodriques et al. (2019) | Brain development | High |
scDam&T-seq | Protein-DNA contacts + RNA | Rooijers et al. (2019) | NA | Low |
Perturb-seq | RNA + CRISPR | Dixit et al. (2016) | Immune cell differentiation | High |
Perturb-ATAC | ATAC + CRISPR | Rubin et al. (2019) | Keratinocyte differentiation | Low |
ScarTrace | RNA + CRISPR | Alemany et al. (2018) | Lineage tracing | Medium |
LINNAEUS | RNA + CRISPR | Spanjaard et al. (2018) | Lineage tracing | High |
LARRY | RNA + exogenous barcode | Weinreb et al. (2020) | Lineage tracing | High |
CellTagging | RNA + exogenous barcode | Biddy et al. (2018) | Lineage tracing | High |
EMBLEM | ATAC + mtDNA | Xu et al. (2019) | Lineage tracing | Low |
ATAC + mtDNA | Ludwig et al. (2019) | Lineage tracing | Low |